Sirolimus Conversion in Liver Transplant Recipients With Calcineurin Inhibitor-Induced Complications: Efficacy and Safety

MLA

Wenhua Liang, et al. “Sirolimus Conversion in Liver Transplant Recipients With Calcineurin Inhibitor-Induced Complications: Efficacy and Safety.” Experimental and Clinical Transplantation, vol. 10, Apr. 2012, pp. 132–35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eed762c9517b11deebb9ba51dfce2396&authtype=sso&custid=ns315887.

APA

Wenhua Liang, Qiang Tai, An Bin Hu, Zhi Yong Guo, Ming Han, Xiaoshun He, Xiao Feng Zhu, Lin Wei Wu, & Wei Qiang Ju. (2012). Sirolimus Conversion in Liver Transplant Recipients With Calcineurin Inhibitor-Induced Complications: Efficacy and Safety. Experimental and Clinical Transplantation, 10, 132–135.

Chicago

Wenhua Liang, Qiang Tai, An Bin Hu, Zhi Yong Guo, Ming Han, Xiaoshun He, Xiao Feng Zhu, Lin Wei Wu, and Wei Qiang Ju. 2012. “Sirolimus Conversion in Liver Transplant Recipients With Calcineurin Inhibitor-Induced Complications: Efficacy and Safety.” Experimental and Clinical Transplantation 10 (April): 132–35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eed762c9517b11deebb9ba51dfce2396&authtype=sso&custid=ns315887.